Seema Mengshetti

Title: Seema Mengshetti: Innovator in Antiviral Research

Introduction

Seema Mengshetti is a prominent inventor based in Decatur, GA (US), known for her significant contributions to antiviral research. With a focus on developing innovative treatments for viral infections, she has been awarded 2 patents that highlight her expertise in the field.

Latest Patents

Her latest patents include groundbreaking work on combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents. This invention discloses nucleoside compounds that include an alkynyl substituent at the 4'-position, aimed at treating or preventing HIV and other viral infections, particularly in macrophages, microglia, and primary myeloid cells. Additionally, she has developed nucleoside analogs for the treatment of the Flaviviridae family of viruses and cancer. This invention targets compounds and methods for treating or preventing infections from viruses such as HCV, Yellow fever, Dengue, Chikungunya, West Nile virus, RSV, HEV, and influenza in human subjects and other animal hosts.

Career Highlights

Seema has worked with esteemed institutions, including Emory University and Cocrystal Pharma, Inc. Her work has significantly advanced the understanding and treatment of viral infections, showcasing her dedication to improving public health through innovative research.

Collaborations

Throughout her career, Seema has collaborated with notable professionals in her field, including Raymond F Schinazi and Franck Amblard. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Seema Mengshetti's contributions to antiviral research and her innovative patents reflect her commitment to addressing critical health challenges. Her work continues to inspire advancements in the treatment of viral infections.